The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Whole exome sequencing (WES) in hormone-receptor positive (HR+) metastatic breast cancer (MBC) to identify mediators of resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i).
 
Seth Andrew Wander
Consulting or Advisory Role - Foundation Medicine; InfiniteMD
 
Ofir Cohen
No Relationships to Disclose
 
Gabriela N Johnson
No Relationships to Disclose
 
Dewey Kim
Patents, Royalties, Other Intellectual Property - Personal Genome Diagnostics
 
Flora Luo
No Relationships to Disclose
 
Pingping Mao
No Relationships to Disclose
 
Utthara Nayar
No Relationships to Disclose
 
Karla Helvie
No Relationships to Disclose
 
Lori Marini
No Relationships to Disclose
 
Samuel Freeman
No Relationships to Disclose
 
Gad Getz
No Relationships to Disclose
 
Levi A. Garraway
Employment - Lilly
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - Bayer
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Third Rock Ventures; Warp Drive Bio
Research Funding - Astellas Pharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; Novartis; Wuxi AppTec
 
Eric P. Winer
Honoraria - Genentech/Roche; Lilly; Tesaro
Consulting or Advisory Role - InfiniteMD; Leap Therapeutics
Research Funding - Genentech (Inst)
 
Nancy U. Lin
Research Funding - Cascadian Therapeutics; Genentech
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases
 
Nikhil Wagle
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Novartis
Research Funding - Merck; Novartis